Please check your internet connection and try again.
# Arsil DX (Dextromethorphan Hydrobromide / Guaifenesin)
## Overview
Arsil DX is a combination non-narcotic antitussive (dextromethorphan) and expectorant (guaifenesin). Dextromethorphan suppresses the cough reflex in the medulla, while guaifenesin increases respiratory tract fluid secretions to facilitate expectoration.
## Primary Indications
Temporary relief of cough due to minor throat and bronchial irritation associated with the common cold or inhaled irritants.
## Adult Dosing
* **Standard dose:** 10–20 mg (dextromethorphan) / 200–400 mg (guaifenesin) every 4 hours, or 30 mg / 600 mg every 6–8 hours.
* **Maximum daily dose:** 120 mg of dextromethorphan / 2,400 mg of guaifenesin per 24 hours.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mg (dextromethorphan) / 100–200 mg (guaifenesin) every 4 hours. Maximum 60 mg dextromethorphan / 1,200 mg guaifenesin per 24 hours.
* **Children < 6 years:** Not recommended without direct medical supervision; safety and efficacy are poorly established.
## Dose Adjustments
Manufacturer labeling does not provide specific renal or hepatic adjustments; however, clinical caution is advised in patients with severe hepatic impairment due to first-pass metabolism of dextromethorphan.
## Contraindications
* Hypersensitivity to dextromethorphan, guaifenesin, or any component.
* Concomitant use with a Monoamine Oxidase Inhibitor (MAOI) or within 14 days of discontinuing an MAOI (risk of serotonin syndrome).
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal pain, dizziness, drowsiness.
* **Serious:** Serotonin syndrome (if used with serotonergic agents), central nervous system depression, or abuse/misuse potential.
## Key Drug Interactions
* **MAOIs:** Fatal reactions reported (serotonin syndrome/hypertensive crisis).
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome.
* **CNS Depressants (Alcohol, Opioids, Sedatives):** Potentiates sedative effects.
* **CYP2D6 Inhibitors (e.g., Fluoxetine, Quinidine):** May significantly increase plasma concentrations of dextromethorphan.
## Monitoring
* Monitor for symptom resolution and cough frequency.
* Assess for signs of serotonin syndrome in patients on concomitant psychotropic medications.
* Discontinue use if cough persists > 7 days, presents with a high fever, or develops a rash/persistent headache.
## Clinical Pearls
* **Efficacy:** Evidence for over-the-counter cough suppressants is historically weak; patient education on hydration is equally important for mucus thinning.
* **Abuse Potential:** Dextromethorphan is a frequent target for recreational abuse in high doses (hallucinogenic/dissociative effects).
* **Product ID:** Always verify the specific concentration, as "DX" products vary significantly by manufacturer.
***
*Disclaimer: This information is for educational purposes and does not replace professional clinical judgment. Always verify current prescribing information, institutional protocols, and local formulary guidelines before administration.*
